Cigna reaffirms 2026 guidance, adds 2030 targets and $3 billion cost plan
The company set new financial targets through 2030 and unveiled a multi-year modernization initiative at its investor day
Published
Chart: CI, one-minute prices, three sessions
The Cigna Group reaffirmed its full-year 2026 guidance on Wednesday, telling investors it still expects consolidated adjusted revenues of approximately $280 billion and adjusted earnings per share of at least $30.45.
At its 2026 Investor Day, the company also laid out new targets running through 2030: adjusted EPS growth of 10% to 14% a year and roughly $50 billion in cumulative operating cash flow over that period. Alongside the targets, Cigna announced a $3 billion multi-year series of modernization and productivity initiatives meant to support growth and financial performance.
The reaffirmed EPS floor gives the market a concrete anchor after a stretch of volatility across managed care tied to elevated medical costs. The 2030 targets point to management's confidence that it can sustain margins over the longer term, while the $3 billion cost program reads more as a defense of earnings through efficiency than a bet on pricing power or volume growth. None of it changes the near-term earnings path already built into estimates, so the setup for Cigna's stock stays largely where it was before the announcements.